Publications récentes
-
31 October 2023 -
9 October 2023 GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics.
Wright SC, Motso A, Koutsilieri S, Beusch CM, Sabatier P, Berghella A, Blondel-Tepaz E, Mangenot K, Pittarokoilis I, Sismanoglou DC, Le Gouill C, Olsen JV, Zubarev RA, Lambert NA, Hauser AS, Bouvier M, Lauschke VM
Nat Commun 2023-10-09 ;14( 1 ):6243 -
6 October 2023 XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells.
Marullo R, Rutherford SC, Revuelta MV, Zamponi N, Culijkovic B, Kotlov N, Di Siervi N, Lara-Garcia J, Allan JN, Ruan J, Furman RR, Chen Z, Shore TB, Phillips AA, Mayer S, Hsu J, van Besien K, Leonard JP, Borden K, Inghirami G, Martin P, Cerchietti L
Cancer Res 2023-10-06 ; -
4 October 2023 RECOVER identifies synergistic drug combinations in vitro through sequential model optimization.
Bertin P, Rector-Brooks J, Sharma D, Gaudelet T, Anighoro A, Gross T, Martínez-Peña F, Tang EL, Suraj MS, Regep C, Hayter JBR, Korablyov M, Valiante N, van der Sloot A, Tyers M, Roberts CES, Bronstein MM, Lairson LL, Taylor-King JP, Bengio Y
Cell Rep Methods 2023-10-04 ;3( 10 ):100599